These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 13601)

  • 1. Comparative evaluation of neuromuscular blockade and reversibility of AH 8165 and pancuronium bromide in man.
    Camu F; Sanders M; D'Hollander A
    Acta Anaesthesiol Belg; 1976; 27 suppl():80-5. PubMed ID: 13601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
    Wali FA
    Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
    Schuh FT
    Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH; deBros FM
    Anesth Analg; 1981 Jan; 60(1):12-7. PubMed ID: 7192943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of a new non-depolarising muscle relaxant.
    Ungerer MJ; Erasmus FR
    S Afr Med J; 1974 Dec; 48(61):2561-4. PubMed ID: 4281529
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.
    Williams A; Gyasi H; Melloni C; Bevan DR
    Can Anaesth Soc J; 1982 Nov; 29(6):567-72. PubMed ID: 6128068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antagonism to neuromuscular effect of subcutaneous administration of pancuronium by neostigmine].
    Iwasaki H; Igarashi M; Omori H; Omote K; Namiki A
    Masui; 1994 Jun; 43(6):885-8. PubMed ID: 8072147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 100-Hertz tetanus as an index of recovery from pancuronium-induced non-depolarizing neuromuscular blockade.
    Kopman AF; Epstein RH; Flashburg MH
    Anesth Analg; 1982 May; 61(5):439-41. PubMed ID: 7199868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of combination nondepolarized neuromuscular block.
    Vitez TS; Difrancesco LV
    Anesth Analg; 1983 Dec; 62(12):1081-2. PubMed ID: 6228170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
    Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent.
    van den Broek L; Lambalk LM; Richardson FJ; Wierda JM
    Anesth Analg; 1991 Jun; 72(6):811-6. PubMed ID: 1674648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.